Deleted Tweets From Scott Gottlieb, R-D.C.
Scott Gottlieb's accounts: SteveFDA
Tracked Between: October 20, 2017-January 20, 2021
SteveFDA (R-D.C.)
@SGottliebFDA
#FDA’s new “Predictive Toxicology Roadmap” and novel methods for toxicity testing will help us move safe products to market more efficiently; reduce reliance on animal testing https://t.co/xOrLiU3vRJ
SteveFDA (R-D.C.)
@SGottliebFDA
New #FDA policy guidance aimed at encouraging development of #digitalhealth tools to help people be more informed about their health https://t.co/wCQwUp5RQ3
SteveFDA (R-D.C.)
@SGottliebFDA
RT @SGottliebFDA: New #FDA data: Antibiotics sales for use in U.S. farm animals dropped in 2016 https://t.co/bR1EkLmKJh
SteveFDA (R-D.C.)
@SGottliebFDA
RT @SGottliebFDA: #FDA’s new “Predictive Toxicology Roadmap” and novel methods for toxicity testing will help us move safe products t… https://t.co/6RlOK00MCh
SteveFDA (R-D.C.)
@SGottliebFDA
RT @SGottliebFDA: New #FDA policy guidance aimed at encouraging development of #digitalhealth tools to help people be more informed a… https://t.co/uOxSYamRRJ
SteveFDA (R-D.C.)
@SGottliebFDA
RT @modrnhealthcr: FDA attempts to ease regulatory burden on software developers https://t.co/0SbEQefXXQ https://t.co/8HSnjNlMhy
SteveFDA (R-D.C.)
@SGottliebFDA
FDA believes strongly people addicted to opioids should have access to safe and effective, approved treatments for addiction. Unfortunately, unscrupulous vendors are trying to capitalize on opioid epidemic by illegally marketing products for these purpose
SteveFDA (R-D.C.)
@SGottliebFDA
In Nov. FDA approved 107 generic drugs - the highest monthly total ever, improving access to affordable medicines. https://t.co/ARc3cNpMBl https://t.co/V53P50jyVy
SteveFDA (R-D.C.)
@SGottliebFDA
RT @califf001: Great delineation of principles. Now much detailed work will be needed to unleash digital technology in a safe and… QT @SGottliebFDA: New #FDA policy guidance aimed at encouraging development of #digitalhealth tools to help people be more informed a… https://t.co/uOxSYamRRJ)
SteveFDA (R-D.C.)
@SGottliebFDA
They’re marketing products as dietary supplements with unproven claims about ability to treat addiction; or as all-natural alternatives to opioids. Health fraud scams like these can pose serious health risks. FDA cautions public to seek out approved medic
SteveFDA (R-D.C.)
@SGottliebFDA
#FDA will continue to act when it learns of the deceptive sale or advertising of products that claim to effectively treat opioid use disorder, but which have not been proven safe and effective for these purposes.
SteveFDA (R-D.C.)
@SGottliebFDA
RT @SGottliebFDA: In Nov. FDA approved 107 generic drugs - the highest monthly total ever, improving access to affordable medicines.… https://t.co/FsKMO6zUen
SteveFDA (R-D.C.)
@SGottliebFDA
RT @FDA_Drug_Info: #FDA again approved more generics in a single month than ever before, 107 in Nov. 2017, improving access to afforda… https://t.co/Vf2VrVOn0n
SteveFDA (R-D.C.)
@SGottliebFDA
RT @SGottliebFDA: FDA believes strongly people addicted to opioids should have access to safe and effective, approved treatments for… https://t.co/xYbFf4esvT
SteveFDA (R-D.C.)
@SGottliebFDA
RT @SGottliebFDA: #FDA outlines new plan to expand its predictive toxicology toolbox; reduce reliance on animal testing for tox studi… https://t.co/QwX4CUmusv
SteveFDA (R-D.C.)
@SGottliebFDA
#FDA outlines new plan to expand its predictive toxicology toolbox; reduce reliance on animal testing for tox studies https://t.co/zbcNqhmb0J https://t.co/HGm6Bx7ZD8
SteveFDA (R-D.C.)
@SGottliebFDA
RT @SGottliebFDA: #FDA again approved more generics in a single month than ever before, breaking the Oct all time high - 107 approval… https://t.co/jyg2bcOvCJ
SteveFDA (R-D.C.)
@SGottliebFDA
RT @tmprowell: Breast cancer pts and pt advocates: what are the barriers to participating in trials? Is it getting easier? We wan… https://t.co/jdb1rppNYU
SteveFDA (R-D.C.)
@SGottliebFDA
RT @tomleblancMD: Important findings from @US_FDA @FDAOncology being presented at #ASH17 re: enrollment of older patients in… https://t.co/ZcyNS4FuCy
SteveFDA (R-D.C.)
@SGottliebFDA
Check out the latest issue of the FDA Patient Network Newsletter and sign up for FDA information https://t.co/aigsuJODIw